Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts

Approved

Publication information

OKM publication type
A1
Category
Artikkelit ja abstraktit
Sub category
Tieteelliset aikakauslehtiartikkelit
Type
Alkuperäisartikkeli
Refereed
Kyllä

Authors of the publication

Authors
Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-Herttuala S et al
Local authors
Unit
A.I. Virtanen -instituutti / Bioteknologia ja molekulaarinen lääketiede

Publication channel information

Title of journal/series
Circulation
ISSN (print)
0009-7322
ISSN (electronic)
1524-4539
ISSN (linking)
0009-7322
Publication forum ID
53475
Internationality
Yes

Detailed publication information

Publication year
2010
Journal/series volume number
121
Page numbers
1413-1422
Language of publication
English

Co-publication information

International co-publication
Yes